Cue Biopharma (CUE) Short Interest Ratio & Short Volume $0.64 0.00 (-0.52%) As of 04:00 PM Eastern Add Compare Share Share Short Interest Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock Cue Biopharma Short Interest DataCue Biopharma (CUE) has a short interest of 774,100 shares, representing 1.39% of the float (the number of shares available for trading by the public). This marks a -13.29% decrease in short interest from the previous month. The short interest ratio (days to cover) is 4.7, indicating that it would take 4.7 days of the average trading volume of 422,929 shares to cover all short positions.Current Short Interest774,100 sharesPrevious Short Interest892,700 sharesChange Vs. Previous Month-13.29%Dollar Volume Sold Short$512.61 thousandShort Interest Ratio4.7 Days to CoverLast Record DateMay 31, 2025Outstanding Shares75,350,000 sharesShort Percent of Float1.39%Today's Trading Volume175,993 sharesAverage Trading Volume422,929 sharesToday's Volume Vs. Average42% Short Selling Cue Biopharma? Sign up to receive the latest short interest report for Cue Biopharma and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort Interest ChartDays to Cover ChartShort Percent of Float ChartCUE Short Interest Over TimeCUE Days to Cover Over TimeCUE Percentage of Float Shorted Over Time Cue Biopharma Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 5/31/2025774,100 shares $512.61 thousand -13.3%1.4%4.7 $0.66 5/15/2025892,700 shares $646.14 thousand +3.0%1.6%5 $0.72 4/30/2025867,100 shares $654.75 thousand -1.9%N/A5.1 $0.76 4/15/2025883,400 shares $706.72 thousand +3.7%1.6%4.5 $0.80 3/31/2025851,900 shares $776.08 thousand -0.9%1.5%3.8 $0.91 3/15/2025859,900 shares $822.84 thousand -10.0%1.5%3.3 $0.96 2/28/2025955,200 shares $1.17 million -6.4%1.7%3.2 $1.23 2/15/20251,020,000 shares $1.52 million -7.3%1.8%3.2 $1.49 1/31/20251,100,000 shares $1.60 million +1.9%N/A2.6 $1.45 1/15/20251,080,000 shares $1.40 million -16.9%N/A2.2 $1.30 Get the Latest News and Ratings for CUE and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Cue Biopharma and its competitors with MarketBeat's FREE daily newsletter. 12/31/20241,300,000 shares $1.42 million +20.4%N/A2.1 $1.09 12/15/20241,080,000 shares $1.02 million +8.0%N/A1.4 $0.94 11/30/20241,000,000 shares $1.22 million -6.5%N/A1.3 $1.22 11/15/20241,070,000 shares $1.33 million -39.9%N/A1.4 $1.25 10/31/20241,780,000 shares $2.87 million -8.7%N/A2.6 $1.61 10/15/20241,950,000 shares $2.18 million -48.7%N/A2.9 $1.12 9/30/20243,800,000 shares $2.88 million +6.7%N/A6.6 $0.76 9/15/20243,560,000 shares $2.10 million +3.8%N/A8.2 $0.59 8/31/20243,430,000 shares $2.48 million -6.3%N/A7.7 $0.72 8/15/20243,660,000 shares $2.17 million -9.2%N/A8.1 $0.59 7/31/20244,030,000 shares $3.37 million +8.3%N/A8.9 $0.84 7/15/20243,720,000 shares $3.46 million -21.5%N/A9.7 $0.93 6/30/20244,740,000 shares $5.88 million +5.6%N/A12.3 $1.24 6/15/20244,490,000 shares $6.11 million +3.2%N/A15.9 $1.36 5/31/20244,350,000 shares $7.09 million -5.2%N/A15.5 $1.63 5/15/20244,590,000 shares $7.53 million -7.5%N/A15.5 $1.64 4/30/20244,960,000 shares $9.42 million +3.8%N/A17.2 $1.90 4/15/20244,780,000 shares $7.62 million +13.8%N/A18.7 $1.60 3/31/20244,200,000 shares $7.94 million +1.9%N/A15.8 $1.89 3/15/20244,120,000 shares $8.53 million +3.8%N/A14.7 $2.07 2/29/20243,970,000 shares $8.24 million +4.2%N/A12.7 $2.08 2/15/20243,810,000 shares $8.95 million +5.8%N/A10.8 $2.35 1/31/20243,600,000 shares $9.50 million -1.4%N/A10.6 $2.64 1/15/20243,650,000 shares $10.91 million +6.7%N/A10.1 $2.99 12/31/20233,420,000 shares $9.03 million +5.2%N/A9.4 $2.64 12/15/20233,250,000 shares $9.20 million +8.3%N/A9.5 $2.83 11/30/20233,000,000 shares $7.50 million -1.0%N/A10 $2.50 11/15/20233,030,000 shares $7.21 million -2.6%N/A11.8 $2.38 10/31/20233,110,000 shares $6.53 million +19.6%N/A10.2 $2.10 10/15/20232,600,000 shares $5.33 million +2.4%N/A8.2 $2.05New Rule Hits in July — The Smart Money Already Moved (Ad)A little-known regulation quietly goes into effect this July. And it's already being exploited by Wall Street and the Big Banks… It gives them the green light to treat a certain tangible asset as equivalent to cold, hard cash. Not stocks. Not real estate. And definitely not the U.S. dollar. We're talking about something they don't want you to notice — because the fewer people who act on this, the better it is for them.To help you get started, we're giving away a FREE Wealth Protection Guide that shows you exactly how 9/30/20232,540,000 shares $5.84 million +2.8%N/A6.7 $2.30 9/15/20232,470,000 shares $6.32 million +1.2%N/A5.2 $2.56 8/31/20232,440,000 shares $6.61 million -20.3%N/A5 $2.71 8/15/20233,060,000 shares $8.60 million -5.9%N/A6.2 $2.81 7/31/20233,250,000 shares $12.42 million +30.0%N/A7.1 $3.82 7/15/20232,500,000 shares $11.13 million +28.2%N/A5.5 $4.45 6/30/20231,950,000 shares $7.12 million +142.2%N/A5.4 $3.65 6/15/2023805,200 shares $3.12 million +10.1%N/A2.5 $3.87 5/31/2023731,600 shares $2.93 million +36.2%N/A3 $4.00 5/15/2023537,100 shares $2.39 million +1.0%N/A2.4 $4.45 4/30/2023531,900 shares $2.30 million -21.6%N/A2.8 $4.33 4/15/2023678,200 shares $2.36 million -10.5%N/A4.8 $3.48 3/31/2023757,900 shares $2.71 million +35.4%N/A5.5 $3.57 3/15/2023559,600 shares $1.75 million +21.8%N/A4.4 $3.12 2/28/2023459,500 shares $1.29 million +4.9%N/A4.3 $2.80 2/15/2023438,000 shares $1.47 million -12.7%N/A3.9 $3.35 1/31/2023501,900 shares $1.72 million -22.1%N/A3.9 $3.42 1/15/2023644,500 shares $2.24 million +8.8%N/A5 $3.48 12/30/2022592,200 shares $1.69 million -17.4%N/A4.4 $2.85 12/15/2022717,000 shares $2.03 million -5.7%N/A4.4 $2.83 11/30/2022759,900 shares $2.93 million -12.9%N/A4.8 $3.86 11/15/2022872,100 shares $3.30 million -29.7%N/A5.4 $3.78 10/31/20221,240,000 shares $3.30 million -10.8%N/A7.6 $2.66 10/15/20221,390,000 shares $3.57 million -6.1%N/A8.2 $2.57 9/30/20221,480,000 shares $3.30 million -12.4%N/A8.2 $2.23 9/15/20221,690,000 shares $5.53 million -12.9%N/A6 $3.27 8/31/20221,940,000 shares $5.70 million No ChangeN/A6.1 $2.94 8/15/20221,940,000 shares $6.48 million -11.0%N/A5.5 $3.34 7/31/20222,180,000 shares $5.93 million -0.5%N/A5.5 $2.72 7/15/20222,190,000 shares $5.76 million -3.5%N/A5.2 $2.63 6/30/20222,270,000 shares $5.65 million -36.6%N/A4.8 $2.49 6/15/20223,580,000 shares $11.06 million -8.7%11.6%7.2 $3.09 5/31/20223,920,000 shares $15.17 million -4.6%12.7%8.3 $3.87 5/15/20224,110,000 shares $14.84 million No Change13.2%8.5 $3.61 4/30/20224,110,000 shares $16.28 million +15.1%13.2%8.5 $3.96 4/15/20223,570,000 shares $16.21 million +6.6%11.5%6.5 $4.54 3/31/20223,350,000 shares $16.35 million -12.3%10.8%6.3 $4.88 3/15/20223,820,000 shares $16.85 million +8.5%N/A8 $4.41 2/28/20223,520,000 shares $20.42 million +1.4%11.5%8.3 $5.80 2/15/20223,470,000 shares $24.64 million +29.0%11.3%8.2 $7.10 1/31/20222,690,000 shares $19.88 million +18.0%8.8%6.5 $7.39 1/15/20222,280,000 shares $22.69 million +11.8%7.4%6.9 $9.95 12/31/20212,040,000 shares $23.07 million +10.9%6.7%6.4 $11.31 12/15/20211,840,000 shares $20.68 million +10.8%6.0%5.8 $11.24 11/30/20211,660,000 shares $20.35 million -8.8%5.4%5.3 $12.26 11/15/20211,820,000 shares $32.49 million -9.9%5.9%6.1 $17.85 10/29/20212,020,000 shares $24.66 million +3.1%6.8%7.8 $12.21 10/15/20211,960,000 shares $24.70 million -2.5%6.6%7.8 $12.60 9/30/20212,010,000 shares $29.29 million -15.6%6.8%8.6 $14.57 9/15/20212,380,000 shares $28.82 million -4.8%8.0%10.6 $12.11Trump’s true trade war strategy (Ad)The media and financial pundits are all misreading Trump’s actions. They think Trump wants to make Canada the 51st state because he’s desperate for critical minerals… They think his involvement in Ukraine is just another resource grab… They think his tariffs will wreck the economy… But they’re all missing the bigger picture.This is fast becoming the world’s most sought-after resource. 8/31/20212,500,000 shares $29.98 million -2.0%8.4%12.7 $11.99 8/13/20212,550,000 shares $28.33 million -3.4%8.6%12.7 $11.11 7/30/20212,640,000 shares $27.51 million -2.2%8.9%6.2 $10.42 7/15/20212,700,000 shares $27.51 million -0.4%9.1%6.2 $10.19 6/30/20212,710,000 shares $31.57 million +1.5%9.1%6 $11.65 6/15/20212,670,000 shares $35.22 million -6.3%9.0%5.9 $13.19 5/28/20212,850,000 shares $40.87 million -5.3%9.6%6.1 $14.34 5/14/20213,010,000 shares $38.98 million +16.2%N/A6 $12.95 4/30/20212,590,000 shares $31.11 million -10.4%N/A5.3 $12.01 4/15/20212,890,000 shares $36.04 million -8.0%N/A9.3 $12.47 3/31/20213,140,000 shares $36.11 million +11.0%N/A10.1 $11.50 3/15/20212,830,000 shares $44.57 million +1.8%N/A8.5 $15.75 2/26/20212,780,000 shares $36.78 million +0.7%N/A8.8 $13.23 2/12/20212,760,000 shares $43.33 million -5.8%N/A9.3 $15.70 1/29/20212,930,000 shares $39.82 million +1.4%N/A10 $13.59 1/15/20212,890,000 shares $36.79 million +4.7%N/A9.8 $12.73 12/31/20202,760,000 shares $35.55 million +3.4%N/A10.4 $12.88 12/15/20202,670,000 shares $36.37 million -6.6%N/A10.4 $13.62 11/30/20202,860,000 shares $39.30 million -0.7%N/A10.8 $13.74 11/15/20202,880,000 shares $34.30 million +5.5%N/A10.3 $11.91 10/30/20202,730,000 shares $33.03 million +11.0%N/A10.3 $12.10 10/15/20202,460,000 shares $38.40 million -5.8%N/A9.3 $15.61 9/30/20202,610,000 shares $39.28 million +12.5%N/A9.9 $15.05 9/15/20202,320,000 shares $41.78 million +7.4%N/A7.5 $18.01 8/31/20202,160,000 shares $38.60 million -0.9%N/A6.6 $17.87 8/14/20202,180,000 shares $44.36 million +1.4%N/A7 $20.35 7/31/20202,150,000 shares $40.66 million +1.4%N/A6.3 $18.91 7/15/20202,120,000 shares $45.24 million +21.8%N/A5.9 $21.34 6/30/20201,740,000 shares $40.65 million +149.4%N/A4.7 $23.36 6/15/2020697,700 shares $19.19 million +12.2%N/A2 $27.50 CUE Short Interest - Frequently Asked Questions What is Cue Biopharma's current short interest? Short interest is the volume of Cue Biopharma shares that have been sold short but have not yet been closed out or covered. As of May 31st, traders have sold 774,100 shares of CUE short. 1.39% of Cue Biopharma's shares are currently sold short. Learn More on Cue Biopharma's current short interest. What is a good short interest ratio for Cue Biopharma? The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. CUE shares currently have a short interest ratio of 5.0. Learn More on Cue Biopharma's short interest ratio. Which institutional investors are shorting Cue Biopharma? As of the most recent reporting period, the following institutional investors, funds, and major shareholders have reported short positions of Cue Biopharma: Simplex Trading LLC. These positions are disclosed in Form 13F filings with the Securities and Exchange Commission. What is a good short interest percentage for Cue Biopharma? Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 1.39% of Cue Biopharma's floating shares are currently sold short. Is Cue Biopharma's short interest increasing or decreasing? Cue Biopharma saw a drop in short interest during the month of May. As of May 31st, there was short interest totaling 774,100 shares, a drop of 13.3% from the previous total of 892,700 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. How does Cue Biopharma's short interest compare to its competitors? 1.39% of Cue Biopharma's shares are currently sold short. Here is how the short interest of companies in the industry of "pharmaceutical products" compare to Cue Biopharma: Lyell Immunopharma, Inc. (8.81%), Voyager Therapeutics, Inc. (6.14%), Nuvectis Pharma, Inc. (19.61%), Organigram Holdings Inc. (6.74%), Ventyx Biosciences, Inc. (10.69%), Eledon Pharmaceuticals, Inc. (2.77%), Puma Biotechnology, Inc. (7.44%), Neumora Therapeutics, Inc. (23.03%), INmune Bio, Inc. (43.02%), DiaMedica Therapeutics Inc. (2.77%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: SPDR S&P 500 ETF Trust ($64.96 billion), Invesco QQQ ($27.88 billion), iShares Russell 2000 ETF ($19.94 billion), iShares 20+ Year Treasury Bond ETF ($9.69 billion), Strategy Incorporated ($8.58 billion), SPDR S&P Biotech ETF ($5.72 billion), Invesco S&P 500 Equal Weight ETF ($5.45 billion), iShares iBoxx $ Investment Grade Corporate Bond ETF ($4.70 billion), Charter Communications, Inc. ($4.54 billion), and Industrial Select Sector SPDR Fund ($4.49 billion). View all of the most shorted stocks. What does it mean to sell short Cue Biopharma stock? Short selling CUE is an investing strategy that aims to generate trading profit from Cue Biopharma as its price is falling. CUE shares are trading down $0.00 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Cue Biopharma? A short squeeze for Cue Biopharma occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of CUE, which in turn drives the price of the stock up even further. How often is Cue Biopharma's short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including CUE, twice per month. The most recent reporting period available is May, 31 2025. More Short Interest Resources from MarketBeat Related Companies LYEL Short Squeeze VYGR Short Squeeze NVCT Short Squeeze OGI Short Squeeze VTYX Short Squeeze ELDN Short Squeeze PBYI Short Squeeze NMRA Short Squeeze INMB Short Squeeze DMAC Short Squeeze Short Interest Tools Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:CUE) was last updated on 6/12/2025 by MarketBeat.com Staff From Our PartnersTrump’s Exec Order #14154 could be a “Millionaire-Maker”Former Presidential Advisor, Jim Rickards, says Trump could “rewire our economy and hand millions of Americans...Paradigm Press | SponsoredGold is soaring. Here’s how to get paid from itGold just broke through $3,300… And while the headlines shout about price targets, something even more powe...Investors Alley | SponsoredElon’s NEXT Big IPO?Cancel your internet TODAY!? Take your latest internet bill and light it on fire… then count the seconds it...Banyan Hill Publishing | Sponsored[No Brainer Gold Play]: “Show me a better investment.”A Historic Gold Announcement Is About to Rock Wall Street? For months, sharp-eyed analysts have watched the...Golden Portfolio | SponsoredWhy Elon put $51 million into thisWhy Elon Musk Just Invested $51 Million Into Brand New “Miracle Metal” Developed by MIT ScientistsTrue Market Insiders | SponsoredTrump’s true trade war strategyThe media and financial pundits are all misreading Trump’s actions. They think Trump wants to make Canada t...Porter & Company | SponsoredBig Changes Coming to Social Security?According to legendary investor Louis Navellier... This new Trump move could soon not only save Social Secu...InvestorPlace | SponsoredSHOCKING: Musk's Pentagon Secret Mission...It's about a harrowing message discovered on December 16, 2024: "美国军方暗杀名单" It's the reason President Tru...Behind the Markets | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Cue Biopharma, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Cue Biopharma With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy CUE Stock Free CUE Stock Alerts